AcelRx Pharmaceuticals Inc - ESG Rating & Company Profile powered by AI
This report of AcelRx Pharmaceuticals Inc employs data from across the internet and also from public filings by AcelRx Pharmaceuticals Inc. The webpage is a zero-cost Environmental, Social and Governance report covering AcelRx Pharmaceuticals Inc. Complete ESG analysis of AcelRx Pharmaceuticals Inc are accessed by signing in.
AcelRx Pharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.8; made up of an environmental score of 2.7, social score of 4.8 and governance score of 4.0.
3.8
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1089 | Zymeworks Inc | 3.9 | Medium |
| 1089 | bluebird bio Inc | 3.9 | Medium |
| 1112 | AcelRx Pharmaceuticals Inc | 3.8 | Medium |
| 1112 | Arcus Biosciences Inc | 3.8 | Medium |
| 1112 | Atreca Inc | 3.8 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does AcelRx Pharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes AcelRx Pharmaceuticals Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes AcelRx Pharmaceuticals Inc report the average age of the workforce?
Sign up for free to unlockDoes AcelRx Pharmaceuticals Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes AcelRx Pharmaceuticals Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes AcelRx Pharmaceuticals Inc disclose cybersecurity risks?
Sign up for free to unlockDoes AcelRx Pharmaceuticals Inc offer flexible work?
Sign up for free to unlockDoes AcelRx Pharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes AcelRx Pharmaceuticals Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes AcelRx Pharmaceuticals Inc conduct supply chain audits?
Sign up for free to unlockDoes AcelRx Pharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes AcelRx Pharmaceuticals Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes AcelRx Pharmaceuticals Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes AcelRx Pharmaceuticals Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes AcelRx Pharmaceuticals Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes AcelRx Pharmaceuticals Inc disclose water use targets?
Sign up for free to unlockDoes AcelRx Pharmaceuticals Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid AcelRx Pharmaceuticals Inc have a product recall in the last two years?
Sign up for free to unlockDoes AcelRx Pharmaceuticals Inc disclose incidents of discrimination?
Sign up for free to unlockDoes AcelRx Pharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas AcelRx Pharmaceuticals Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes AcelRx Pharmaceuticals Inc disclose parental leave metrics?
Sign up for free to unlockDoes AcelRx Pharmaceuticals Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes AcelRx Pharmaceuticals Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes AcelRx Pharmaceuticals Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes AcelRx Pharmaceuticals Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes AcelRx Pharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes AcelRx Pharmaceuticals Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs AcelRx Pharmaceuticals Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes AcelRx Pharmaceuticals Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes AcelRx Pharmaceuticals Inc disclose its waste policy?
Sign up for free to unlockDoes AcelRx Pharmaceuticals Inc report according to TCFD requirements?
Sign up for free to unlockDoes AcelRx Pharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes AcelRx Pharmaceuticals Inc disclose energy use targets?
Sign up for free to unlockDoes AcelRx Pharmaceuticals Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes AcelRx Pharmaceuticals Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for AcelRx Pharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed and patient-controlled analgesia system that allows hospital patients with moderate-to-severe acute pain to self-dose with sufentanil sublingual tablets to manage their pain; ARX-02, which is in Phase 2 clinical trial for the treatment of cancer breakthrough pain in opioid-tolerant patients; and 4ARX-03 for mild sedation and pain relief during painful procedures. Its product candidates also include Niyad, a regional anticoagulant for the extracorporeal circuit; and LTX-608, a nafamostat formulation for direct IV infusion being explored as an investigational product for antiviral treatment of COVID, acute respiratory distress syndrome, disseminated intravascular coagulation, and acute pancreatitis. The company was formerly known as SuRx, Inc. and changed its name to AcelRx Pharmaceuticals, Inc. in August 2006. AcelRx Pharmaceuticals, Inc. was incorporated in 2005 and is based in Hayward, California.